Key result
Circulating chemerin shows no independent association with central arterial stiffness.
Why the study?
Is circulating chemerin independently associated with central arterial stiffness (carotid-femoral pulse wave velocity) in a community-based population?
Cross-Sectional (n=1,304)
No
Is circulating chemerin independently associated with central arterial stiffness (carotid-femoral pulse wave velocity) in a community-based population?
Mean Difference: 0.093 (95% CI -0.026–0.212)
p-value: p=0.126
Circulating chemerin is not independently associated with central arterial stiffness when adjusted for traditional cardiovascular and metabolic risk factors.
Chemerin is a multifunctional adipokine involved in metabolic regulation, inflammation, and vascular homeostasis, but its relationship with arterial stiffness remains uncertain. We investigated the association between circulating chemerin and carotid–femoral pulse wave velocity (cfPWV) and explored individual chemerin–PWV discordance in participants from the Brisighella Heart Study (n = 1304). Multivariable linear regression was adjusted for age, sex, body mass index, mean arterial pressure, resting heart rate, current smoking, and estimated glomerular filtration rate. Chemerin was correlated with cfPWV in unadjusted analysis (Spearman’s ρ = 0.073; p = 0.009). After adjustment, each one-standard-deviation increase in chemerin was associated with a nonsignificant 0.093 m/s higher cfPWV (95% confidence interval, −0.026 to 0.212; p = 0.126). Residual-based classification identified 132 participants with higher-than-expected chemerin and lower-than-expected cfPWV and 151 with higher-than-expected values of both measures. No investigated factor remained associated with membership in the former group after false-discovery-rate correction. Cross-fitting showed 95.6% agreement in phenotype classification. Circulating chemerin was not independently associated with central arterial stiffness, while residual analysis revealed stable but clinically unvalidated patterns of chemerin–cfPWV discordance.
No takes yet. Share an insight, caveat, or question.
Fogacci et al. (2026) conducted a cross-sectional in Arterial Stiffness (n=1,304). Circulating chemerin vs. Lower chemerin levels (per one-standard-deviation increase) was evaluated on Carotid-femoral pulse wave velocity (cfPWV) (β = 0.093 m/s, 95% CI -0.026 to 0.212, p=0.126). Circulating chemerin was not independently associated with central arterial stiffness, as each one-standard-deviation increase in chemerin corresponded to a nonsignificant 0.093 m/s higher pulse wave velocity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: